EquiBalance™ Reta

Retatrutide (Triple Agonist Peptide)

Molecular Formula

C₂₂₁H₃₄₂N₄₆O₆₈

Retatrutide is a next-generation, long-acting 39-amino-acid peptide designed as a triple receptor agonist, targeting the GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors. This multi-pathway approach enables comprehensive metabolic regulation and advanced weight management support.

Product Overview

Retatrutide represents a novel class of metabolic peptides engineered to optimize body composition, energy balance, and glycemic control. By simultaneously activating three key metabolic hormone pathways, it delivers enhanced effects on appetite regulation, fat metabolism, and energy expenditure beyond single- or dual-agonist compounds.

Key Benefits

1. Advanced Weight Management

• Significantly reduces appetite and caloric intake

• Promotes substantial and sustained weight loss

• Supports long-term body composition improvements

1. Enhanced Fat Loss & Metabolic Rate

• Activates glucagon pathways to increase energy expenditure

• Encourages breakdown of stored fat (lipolysis)

• Helps preserve lean muscle mass during weight loss

1. Blood Glucose Regulation

• Improves insulin sensitivity and glucose uptake

• Supports stable blood sugar levels

• Reduces postprandial glucose spikes

1. Appetite & Satiety Control

• Slows gastric emptying for prolonged fullness

• Regulates hunger signaling in the brain

• Reduces cravings and overeating behaviors

1. Cardiometabolic Support

• May improve lipid profiles (cholesterol and triglycerides)

• Supports cardiovascular health markers

• Contributes to overall metabolic efficiency

1. Next-Generation Multi-Pathway Efficacy

• Combines GLP-1, GIP, and glucagon receptor activation

• Offers broader metabolic impact than GLP-1-only peptides

• Designed for superior efficacy in weight and metabolic optimization

Mechanism of Action

Retatrutide works by activating three key hormone receptors involved in metabolism:

• GLP-1 receptor: Enhances insulin secretion, reduces appetite, and slows gastric emptying

• GIP receptor: Supports insulin response and metabolic regulation

• Glucagon receptor: Increases energy expenditure and promotes fat utilization

This triple-agonist mechanism creates a synergistic effect, improving energy balance, glucose control, and fat metabolism simultaneously.